Tyra Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.8%.

Top 25 shareholders own 95.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.8%	RA Capital Management, L.P.	10,416,609	US$193.0m	44%	2.3%
12.3%	Tavistock Life Sciences	6,448,359	US$119.5m	0%	6.19%
8.87%	BVF Partners L.P.	4,661,194	US$86.4m	70.1%	1.87%
8.86%	FMR LLC	4,654,276	US$86.2m	68.1%	0.01%
8.4%	Canaan Management, Inc.	4,409,991	US$81.7m	0%	37.99%
7.77%	Alta Partners LP	4,080,296	US$75.6m	0%	90.62%
7.72%	Nextech Invest Ltd.	4,055,861	US$75.2m	61%	11.6%
3.79%	TCG Crossover Management, LLC	1,989,103	US$36.9m	0%	2.93%
2.86%	Todd Harris	1,504,577	US$27.9m	-6.12%	no data
2.65%	Fairmount Funds Management LLC	1,393,329	US$25.8m	0%	2.28%
1.95%	Frazier Life Sciences Management, LP	1,026,420	US$19.0m	-0.15%	0.72%
1.84%	BlackRock, Inc.	965,034	US$17.9m	7.65%	no data
1.44%	The Vanguard Group, Inc.	758,967	US$14.1m	3.6%	no data
1.06%	5AM Venture Management, LLC	554,979	US$10.3m	34.9%	1.84%
0.82%	Daniel Bensen	431,683	US$8.0m	-18.2%	no data
0.69%	JP Morgan Asset Management	364,056	US$6.7m	-1.91%	no data
0.69%	Perceptive Advisors LLC	360,000	US$6.7m	0%	0.14%
0.65%	Kynam Capital Management, LP	340,190	US$6.3m	0%	0.43%
0.63%	Geode Capital Management, LLC	333,469	US$6.2m	6.04%	no data
0.52%	Robert Hudkins	273,576	US$5.1m	0%	no data
0.51%	State Street Global Advisors, Inc.	265,354	US$4.9m	2.27%	no data
0.39%	Driehaus Capital Management LLC	203,709	US$3.8m	35.4%	0.02%
0.37%	Isan Chen	192,783	US$3.6m	0%	no data
0.29%	Northern Trust Global Investments	152,250	US$2.8m	7.52%	no data
0.27%	Esther van den Boom	143,151	US$2.7m	0%	no data